Van Lanschot Kempen Investment Management N.V. Purchases 4,640 Shares of Danaher Corporation $DHR

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Van Lanschot Kempen Investment Management N.V. grew its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 0.8% during the first quarter, according to its most recent filing with the SEC. The firm owned 558,202 shares of the conglomerate's stock after acquiring an additional 4,640 shares during the period. Danaher comprises about 1.2% of Van Lanschot Kempen Investment Management N.V.'s holdings, making the stock its 23rd largest holding. Van Lanschot Kempen Investment Management N.V. owned about 0.08% of Danaher worth $114,431,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. Berkshire Asset Management LLC PA grew its holdings in shares of Danaher by 130.4% during the 1st quarter. Berkshire Asset Management LLC PA now owns 2,995 shares of the conglomerate's stock worth $584,000 after acquiring an additional 1,695 shares during the period. Texas Capital Bancshares Inc TX grew its holdings in shares of Danaher by 1.7% during the 1st quarter. Texas Capital Bancshares Inc TX now owns 3,714 shares of the conglomerate's stock worth $761,000 after acquiring an additional 63 shares during the period. Texas Capital Bank Wealth Management Services Inc grew its holdings in shares of Danaher by 6.1% during the 1st quarter. Texas Capital Bank Wealth Management Services Inc now owns 34,763 shares of the conglomerate's stock worth $7,126,000 after acquiring an additional 2,009 shares during the period. Colonial Trust Advisors grew its holdings in shares of Danaher by 200.4% during the 1st quarter. Colonial Trust Advisors now owns 784 shares of the conglomerate's stock worth $161,000 after acquiring an additional 523 shares during the period. Finally, Senator Investment Group LP purchased a new position in shares of Danaher during the 1st quarter worth approximately $41,000,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Robert W. Baird upped their price target on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research note on Friday, July 18th. UBS Group cut their price target on Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a research note on Wednesday, July 23rd. Scotiabank upgraded Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target on the stock in a research note on Friday, July 11th. Barclays restated an "overweight" rating and issued a $225.00 price target (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Finally, Evercore ISI cut their price target on Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research note on Tuesday, July 8th. Seventeen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat, Danaher currently has a consensus rating of "Moderate Buy" and an average price target of $247.61.

Danaher Stock Up 3.8%

DHR traded up $7.8060 during trading on Friday, hitting $211.7060. 3,364,884 shares of the company's stock traded hands, compared to its average volume of 4,223,297. The company's 50 day simple moving average is $200.45 and its two-hundred day simple moving average is $199.55. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.90. The stock has a market capitalization of $151.59 billion, a price-to-earnings ratio of 45.04, a PEG ratio of 2.95 and a beta of 0.73.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same period last year, the business posted $1.72 EPS. The company's revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.